Researchers find a higher than expected risk of myocarditis in young men after full vaccination.

According to a large new study published on Wednesday in the New England Journal of Medicine, males aged 16 to 29 have an increased risk of developing myocarditis after receiving a second dose of mRNA coronavirus vaccines manufactured by Pfizer-BioNtech or Moderna.

NYTimes Health | Disclosure